Employees Provident Fund Board Takes Position in Cencora, Inc. $COR

Employees Provident Fund Board purchased a new stake in shares of Cencora, Inc. (NYSE:COR) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 72,000 shares of the company’s stock, valued at approximately $24,318,000.

Other hedge funds have also recently bought and sold shares of the company. Kemnay Advisory Services Inc. bought a new stake in shares of Cencora during the 4th quarter valued at $25,000. Oakworth Capital Inc. acquired a new stake in Cencora in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC bought a new stake in Cencora during the 4th quarter worth $27,000. Archer Investment Corp grew its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new stake in Cencora during the 4th quarter worth approximately $29,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

COR has been the subject of a number of analyst reports. UBS Group lifted their target price on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Weiss Ratings lowered Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 22nd. Robert W. Baird cut their price target on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. Morgan Stanley set a $342.00 price target on shares of Cencora in a research report on Friday, May 8th. Finally, William Blair assumed coverage on Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $374.00.

Cencora Stock Up 0.1%

Shares of NYSE COR opened at $271.99 on Friday. The firm’s 50 day simple moving average is $284.59 and its two-hundred day simple moving average is $324.35. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The stock has a market capitalization of $52.92 billion, a P/E ratio of 20.86, a PEG ratio of 1.47 and a beta of 0.59. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59.

Cencora (NYSE:COR) last released its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same period last year, the firm posted $4.42 EPS. The company’s revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora declared that its Board of Directors has initiated a share repurchase plan on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.

Cencora Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.